Patent ID: 11866445
Assignee: UNION THERAPEUTICS A/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 26:
27. The method according to claim 18, wherein the compound is administered to the subject concomitantly or sequentially with one or more other active agents selected from the group consisting of a glucocorticoid, vitamin D, a vitamin D analogue, an antihistamine, a platelet activating factor antagonist, an anticholinergic agent, a methylxanthine, a β-adrenergic agent, a COX-2 inhibitor, a JAK inhibitor, a PDE inhibitor, a salicylate, indomethacin, flufenamate, naproxen, timegadine, a gold salt, penicillamine, a serum cholesterol lowering agent, a retinoid, a zinc salt, salicylazosulfapyridine and a calcineurin inhibitor.